Research News

Share on

Filter by year:

Adult Neurogenesis in Mammals: Variations and Confusions.

Brain Behavior and Evolution , August 2016
Luca Bonfanti and Hans-Peter Lipp

29 august 2016

Successful in vivo MRI tracking of MSCs labeled with Gadoteridol in a Spinal Cord Injury experimental model

Experimental Neurology , August 2016
Filippi M, Boido M, Pasquino C, Garello F, Boffa C, Terreno E

24 august 2016

Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse.

Scientific Reports
 Pellegrino RM, Boda E, Montarolo F, Boero M, Mezzanotte M, Saglio G, Buffo A, Roetto A

21 august 2016

Adult exposure to tributyltin affects hypothalamic neuropeptide Y, Y1 receptor distribution, and circulating leptin in mice

Andrology, June 2016
E. Bo, A. Farinetti, M. Marraudino, D. Sterchele, C. Eva, S. Gotti, G. Panzica

19 june 2016

Science-based regulation of endocrine disrupting chemicals in Europe: which approach?

The Lancet: Diabetology and Endocrinology
Bourguignon J-P, Slama R, Bergman A, Demeneix B, Ivell R, Kortenkamp A, Panzica G, Trasande L, Zoeller R.T.

13 june 2016

Starting academic cooperation with Praga

We signed a 4 years agreement with The Institute of Experimental Medicine Academy of Sciences of the Czech Republic in order to develop collaborative activities such as exachangin of researchers and students and conducting research projects.

7 june 2016

Scientific Issues Relevant to Setting Regulatory Criteria to Identify Endocrine Disrupting Substances in the European Union

Endocrine Disruptors (EDs) are defined by WHO as exogenous compounds or mixtures that alter function(s) of the endocrine system and consequently cause adverse effects in an intact organism, or its progeny, or (sub)populations. European regulations on pesticides, biocides, cosmetics, and industrial chemicals require the European Commission to establish scientific criteria to define EDs.

25 april 2016